Dunvegan Associates’s Clorox CLX Stock Holding History

Dunvegan Associates’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$489K	Sell	3,857 -123	-3%	-$15.3K	0.57%	37
2015 Q3	$460K	Sell	3,980 -160	-4%	-$18K	0.52%	39
2015 Q2	$431K	Hold	4,140	–	–	0.48%	34
2015 Q1	$457K	Hold	4,140	–	–	0.4%	43
2014 Q4	$431K	Buy	4,140 +130	+3%	+$13K	0.37%	45
2014 Q3	$385K	Hold	4,010	–	–	0.35%	42
2014 Q2	$367K	Hold	4,010	–	–	0.31%	45
2014 Q1	$353K	Sell	4,010 -515	-11%	-$45.2K	0.3%	47
2013 Q4	$420K	Hold	4,525	–	–	0.35%	51
2013 Q3	$370K	Hold	4,525	–	–	0.27%	58
2013 Q2	$376K	Buy	+4,525	New	+$389K	0.29%	58

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

CRC

Cedar Rock Capital London, United Kingdom $4.05B AUM 21.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Analytic Investors Los Angeles, California $8.93B AUM 13.54% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dunvegan Associates's CLX Position: Q4 2015 in Review

Dunvegan Associates reduced its Clorox (CLX) stake by 3.1% in Q4 2015, selling an estimated $15.3K and leaving 3,857 shares worth $489K. The position accounts for 0.57% of the portfolio, ranked #37.

Dunvegan Associates first reported a position in CLX in Q2 2013 and has held it in 11 quarters since. 830 funds tracked by Wall St. Rank hold CLX as of Q4 2015.

Dunvegan Associates held 3,857 shares of Clorox worth $489K as of Q4 2015.
Dunvegan Associates sold 123 Clorox shares in Q4 2015, an estimated $15.3K.
Clorox made up 0.57% of Dunvegan Associates's portfolio in Q4 2015, its #37 holding.
Dunvegan Associates first reported a position in Clorox in Q2 2013 and has held it in 11 quarters since.
830 funds tracked by Wall St. Rank held Clorox as of Q4 2015.

Based on Dunvegan Associates's 13F filing for Q4 2015, filed 28 Apr 2017.